BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9731895)

  • 41. [Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006].
    Vaylet F; Bonnichon A; Salles Y; Gontier E; Bonardel G; Lefloch H; Mairovitz A; Mantzarides M; Niang A; Marotel C; Foehrenbach H
    Cancer Radiother; 2007; 11(1-2):16-22. PubMed ID: 17137819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Introduction to clinical positron emission tomography.
    Agress H
    N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1999 plenary session: Friday imaging symposium : evaluation of focal pulmonary abnormalities with FDG PET.
    Patz EF
    Radiographics; 2000; 20(4):1182-5. PubMed ID: 10903708
    [No Abstract]   [Full Text] [Related]  

  • 44. [Contribution of positron emission tomography for the management of lung cancer].
    Bury T; Rigo P
    Rev Pneumol Clin; 2000 Apr; 56(2):125-31. PubMed ID: 10810198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiation-induced esophagitis on FDG PET imaging.
    Bhargava P; Reich P; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Oct; 28(10):849-50. PubMed ID: 14508282
    [No Abstract]   [Full Text] [Related]  

  • 46. FDG-PET in radiotherapy treatment planning: Pandora's box?
    Paulino AC; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):4-5. PubMed ID: 15093892
    [No Abstract]   [Full Text] [Related]  

  • 47. Fluorodeoxyglucose uptake predicts survival in a CT screening trial.
    Erasmus JJ
    J Thorac Oncol; 2009 Nov; 4(11):1305-6. PubMed ID: 19861902
    [No Abstract]   [Full Text] [Related]  

  • 48. Differentiation of synchronous tumors using FDG positron emission tomography.
    Wilkinson MD; Fulham MJ; McCaughan BC; Constable CJ
    Clin Nucl Med; 2003 Jun; 28(6):489-91. PubMed ID: 12917532
    [No Abstract]   [Full Text] [Related]  

  • 49. Intracardiac extension of lung cancer demonstrated on PET scanning.
    Gates GF; Aronsky A; Ozgur H
    Clin Nucl Med; 2006 Feb; 31(2):68-70. PubMed ID: 16424687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The heart or a tumor? Lung cancer in the lower left thorax can mimic myocardial FDG uptake on PET imaging.
    Ponzo F; Zhuang H; Woodfield C; Alavi A
    Clin Nucl Med; 2003 Feb; 28(2):146-9. PubMed ID: 12544141
    [No Abstract]   [Full Text] [Related]  

  • 51. [Non-small cell lung carcinoma--Will Rogers phenomenon and better survival are jointly responsible].
    Pneumologie; 2008 Dec; 62(12):703. PubMed ID: 19065509
    [No Abstract]   [Full Text] [Related]  

  • 52. Bronchogenic carcinoma associated with rheumatoid arthritis: role of FDG-PET scans.
    Rodríguez P; Romero T; Rodríguez de Castro F; Hussein M; Freixinet J
    Rheumatology (Oxford); 2006 Mar; 45(3):359-60. PubMed ID: 16436491
    [No Abstract]   [Full Text] [Related]  

  • 53. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism.
    Hunter GJ; Hamberg LM; Choi N; Jain RK; McCloud T; Fischman AJ
    Clin Cancer Res; 1998 Apr; 4(4):949-55. PubMed ID: 9563889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography].
    Vaylet F; Foehrenbach H; De Dreuille O; Maszelin P; Merlet P; Bendriem B; L'Her P; Syrota A; Gaillard JF
    Rev Pneumol Clin; 1998 Sep; 54(4):187-95. PubMed ID: 9805748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Silicosis callosities or bronchial carcinoma: on the problem of functional differentiation using FDG-PET].
    Zell L; Hellwig D; Sommerfeld A; Ukena D; Buchter A; Kirsch CM
    Nuklearmedizin; 2000; 39(3):N35-8. PubMed ID: 10834198
    [No Abstract]   [Full Text] [Related]  

  • 56. Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma.
    Takekawa H; Takaoka K; Tsukamoto E; Kanegae K; Miller F; Kawakami Y
    Cancer; 1997 Jul; 80(2):198-203. PubMed ID: 9217030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance evaluation of 4 measuring methods of ground-glass opacities for predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer: a multicenter study.
    Kakinuma R; Kodama K; Yamada K; Yokoyama A; Adachi S; Mori K; Fukuyama Y; Kuriyama K; Oda J; Noguchi M; Matsuno Y; Yokose T; Ohmatsu H; Nishiwaki Y
    J Comput Assist Tomogr; 2008; 32(5):792-8. PubMed ID: 18830114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The usefulness of positron emission tomography in nonsmall cell lung carcinoma].
    Resino MC; Maldonado A; García L
    Arch Bronconeumol; 2004 Mar; 40(3):103-5. PubMed ID: 14998472
    [No Abstract]   [Full Text] [Related]  

  • 59. Ring-shaped FDG uptake in the right lower lung: is it always a tumor?
    Bhargava P; Zhuang H; Kumar R; Yu JQ; Alavi A
    Clin Nucl Med; 2004 May; 29(5):324-5. PubMed ID: 15069336
    [No Abstract]   [Full Text] [Related]  

  • 60. Unsubstantiated conclusions can impede progress in lung cancer.
    Beitler JJ
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1337. PubMed ID: 10766569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.